Please wait
Exhibit 10.49
NEUROLOGIX,
INC.
One Bridge Plaza
Suite 605
Fort Lee, New Jersey 07024
March 1,
2010
Mr. John E. Mordock
***
***
Dear John:
This letter (the “Agreement and Release”) confirms our
agreement with regard to your resignation as an officer and
director of Neurologix, Inc. (the “Company”),
effective on the Separation Date (as hereinafter defined in
paragraph 14). Our understanding and agreement with respect
to your resignation is as follows:
1. As of February 26, 2010
(the “Resignation Date”), you have resigned from your
employment as the President and Chief Executive Officer of the
Company, and from your position as a director on the
Company’s board of directors, which resignations shall
become effective on the Separation Date. You further acknowledge
and agree that the resignation set forth in this
paragraph 1 constitute your written resignation notice in
accordance with the Company’s bylaws and that an executed
copy of this Separation and Release Agreement will be forwarded
to the Chairman of the Company’s board of directors.
2. Your total unconditional
compensation, payments and benefits from the Company shall be as
follows (in each case less applicable statutory deductions and
authorized withholdings):
a. You will receive all accrued and
unpaid current base salary through the Resignation Date.
b. You will be paid for all accrued
but unused vacation as of the Resignation Date.
c. You will be reimbursed for
unpaid business expenses you have incurred and submitted for
payment to the Company through the Resignation Date.
Nothing in this Agreement and Release is intended to impair any
of these rights.
3. Provided you agree to and accept
the terms of this Agreement and Release and do not timely revoke
your acceptance, you shall be eligible for the following
benefits:
a. You will be paid in a lump sum,
on the Separation Date, the amount of two hundred seventy-five
thousand dollars and no cents ($275,000.00), less applicable
statutory deductions and authorized withholdings, representing
one year of your current base salary.
b. The eight hundred thousand
(800,000) unexercised stock options previously granted to you
shall be deemed fully vested and exercisable as of the
Separation Date. These stock options shall continue to be
exercisable until the earlier of (i) one year after the
Separation Date or (ii) their expiration date as specified
in the applicable option award letters.
c. You will be paid in a lump sum,
on the Separation Date, the amount of fifteen thousand eight
hundred twenty-four dollars and sixty-four cents ($15,824.64),
less applicable statutory deductions and authorized
withholdings, representing the sum of the annual cost of the
Life/STD/LTD premium ($1,268.40) and medical premium
reimbursement ($14,556.24) that you received immediately prior
to the Resignation Date.
1
d. The benefits described in
subparagraphs 3(a) through (c) shall be referenced in this
Agreement and Release collectively as the “Separation
Benefits.”
e. Upon your execution and delivery
of this Agreement and Release, the Company will prepare a check
made payable to you for the portion of the Separation Benefits
provided for in subparagraphs 3(a) and 3(c). The check will have
a posted date for the eighth day following the date of execution
of this Agreement and Release. Said check will be held by Marc
Panoff in his capacity as the Company’s Chief Financial
Officer, and delivered to you on the Separation Date.
4. You have ceased to participate
in all of the Company’s benefit plans and programs as of
the Resignation Date.
5. Other than as set forth in this
Agreement and Release, you acknowledge and agree that you are
not entitled to and will not receive any additional
compensation, payments or benefits of any kind from the
Releasees (as that term is defined in subparagraph 7(b)),
including, without limitation, any notice or separation payments
otherwise due under any offer letter, letter of employment or
the Employment Agreement between you and the Company, dated
August 20, 2009 (the “Employment Agreement”), and
that no representations or promises to the contrary have been
made to you.
6. The Company will not object to
any lawful application by you to receive unemployment benefits.
7. a. As a condition of the
Company’s willingness to enter into this Agreement and
Release, and in consideration for the agreements of the Company
contained herein, you hereby release, waive and forever
discharge the Releasees from, and hereby acknowledge full accord
and satisfaction of, any and all claims, demands, causes of
action, and liabilities of any kind whatsoever (upon any legal
or equitable theory, whether contractual, common law or
statutory, under federal, state or local law or otherwise),
whether known or unknown, asserted or unasserted, by reason of
any act, omission, transaction, agreement or occurrence that you
ever had, now have or hereafter may have against the Releasees
up to and including the Separation Date.
Without limiting the generality of the foregoing, you hereby
release and forever discharge the Releasees from:
(i) any and all claims relating to
or arising from your employment with the Company, the terms and
conditions of that employment, and the termination of that
employment;
(ii) any and all claims of
employment discrimination, harassment or retaliation under any
federal, state or local statute or ordinance, public policy or
the common law, including, without limitation, any and all
claims under Title VII of the Civil Rights Act of 1964, the
Civil Rights Acts of 1866 and 1991, the Americans with
Disabilities Act, the Age Discrimination in Employment Act,
the Older Workers Benefit Protection Act, the Worker Adjustment
and Retraining Notification Act, the Sarbanes-Oxley Act, the
Family & Medical Leave Act, the New York State and New
York City Human Rights Laws, the New York Labor Law, the New
York Worker Adjustment and Retraining Notification Act, the New
York Whistleblower Law, the New York Constitution, the New
Jersey Law Against Discrimination, the New Jersey Conscientious
Employee Protection Act, the New Jersey Equal Pay Act, the New
Jersey Smokers’ Rights Law, the New Jersey Family Leave
Act, the New Jersey Millville Dallas Airmotive Plant Job Loss
Notification Act, the New Jersey State Wage and Hour Law, the
New Jersey State Wage Payment Law, the New Jersey Constitution,
and as all such laws have been amended;
2
(iii) any and all contract claims
(including, without limitation, under the Employment Agreement),
claims for bonuses, or severance allowances or entitlements;
(iv) any and all claims for
employee benefits, including, without limitation, any and all
claims under the Employee Retirement Income Security Act of
1974, as amended; provided, however, that nothing in this
paragraph 7 is intended to release, diminish, or otherwise
affect any vested monies or other vested benefits to which you
may be entitled from, under, or pursuant to any savings or
retirement plan of the Company;
(v) any and all claims for slander,
libel, defamation, negligent or intentional infliction of
emotional distress, personal injury, prima facie tort,
negligence, compensatory or punitive damages, or any other claim
for damages or injury of any kind whatsoever; and
(vi) any and all claims for
monetary recovery, including, without limitation,
attorneys’ fees, experts’ fees, medical fees or
expenses, costs and disbursements and the like.
This Agreement and Release is not intended to and does not
affect any rights or claims you may have arising after the
Separation Date. Moreover, the release set forth in this
subparagraph 7 (a) shall exclude any of your rights or
claims arising under paragraphs 2 and 3 hereof.
b. For purposes of this Agreement
and Release, the term “Releasees” includes the
Company, its present and former direct and indirect parents,
affiliates, divisions, subsidiaries, predecessors, successors
and assigns, and their present and former officers, directors,
managers, general partners, employees, consultants,
representatives, attorneys and agents, whether acting as agents
or in individual capacities, and the Company’s pension and
welfare benefit plans (and their respective administrators,
fiduciaries, trustees and insurers), whether acting as agents or
in individual capacities, and this release shall inure to the
benefit of and shall be binding upon and enforceable by all such
entities and individuals.
8. You have not been told that the
Company or any Releasee will employ you in the future, and you
agree that the Company shall not have any obligation in the
future to reemploy you, or enter into any other business
arrangement of any kind with you.
9. a. You agree to return to the
Company, on or before the date of this Agreement and Release
(the “Agreement Date”), any computer equipment, cell
phones, Black Berry devices or other TDAs, office keys, credit
cards, ID and access cards, etc., and any and all original and
duplicate copies of your work product and of files, calendars,
books, employee handbooks, records, notes, notebooks, manuals,
computer disks, diskettes and any other magnetic and other media
materials you have in your possession or under your control
belonging to the Company, or containing confidential or
proprietary information concerning the Company, and its
officers, directors, employees, consultants, customers,
activities or operations. By signing this Agreement and Release,
you confirm and acknowledge that you will not retain in your
possession or under your control any of the documents or
materials described in this subparagraph 9(a) or any
reproduction of the same, and that you are not entitled to
receive the Separation Benefits unless this obligation is fully
satisfied. Your agreements, acknowledgments and obligations
under this paragraph 9(a) are supplemental to, and not a
replacement of, your agreements, acknowledgments and obligations
contained in the Confidentiality Agreement (as hereafter
defined).
b. You acknowledge that, on
July 17, 2006, you executed a Confidentiality, Proprietary
Information and Inventions Agreement (the “Confidentiality
Agreement”) with the Company relating to the disclosure and
use of the Company’s confidential information and to the
protection of the Company’s trade secrets and other
intellectual property. You hereby acknowledge that you have
complied with all of the provisions of the Confidentiality
Agreement, that the Confidentiality Agreement is in full force
and effect as of the Agreement Date and that the terms of the
Confidentiality Agreement are deemed
3
incorporated fully into this Agreement and Release as if fully
set forth herein. The Confidentiality Agreement shall remain in
full force and effect and shall survive the execution and
delivery of this Agreement and Release and the Separation Date.
As a term and condition of this Agreement and Release, you agree
to waive and release to the Company any and all claims to
ownership that you or your assigns may have to the intellectual
property known as the Neurologix Infusion System.
c. You agree to cooperate with the
Company with respect to: (i) any inquiries or other
matters, including any legal or administrative proceedings
brought against the Company, that relate to or arise out of your
employment with or service as a director of the Company; and
(ii) any inquiries or other matters that relate to or arise
out of the transition of your former responsibilities as
President and Chief Executive Officer, or as a director, of the
Company. Nothing in this Agreement and Release shall impair
rights of indemnification that you may have, if any, under the
Company’s corporate policies or constituent documents, with
respect to matters that relate to or arise out of your prior
employment with, or service as a director of, the Company. The
Company acknowledges that as of the date of this Agreement and
Release, you are covered as an officer under the Company’s
D&O insurance policy.
d. Nothing in this Agreement and
Release is intended to or will limit your right to provide
truthful and complete information to judicial or administrative,
governmental or regulatory authorities, in connection with any
investigation involving the Releasees, or any of them.
10. a. You agree that you will take
no action that is intended, or would reasonably be expected, to
harm or disparage the Releasees, or any of them, or to impair
any of their reputations.
b. The Company will instruct its
current directors and executive officers to take no action that
is intended, or would reasonably be expected, to harm or
disparage you, or to impair your reputation.
c. As a courtesy, the Company will
provide you, in advance, with a copy of any press release that
it proposes to issue relating to your resignation as an officer
and director. However, your prior approval of the contents of
the press release will not be required before it may be issued
by the Company.
11. The making of this Agreement
and Release is not intended, and shall not be construed, as an
admission that: (a) the Releasees, or any of them, have
violated any federal, state or local law, ordinance or
regulation, breached any contract, or committed any wrong
whatsoever against you; or (b) you have violated any
federal, state or local law, ordinance or regulation, breached
any contract, or committed any wrong whatsoever against the
Releasees, or any of them.
12. You agree that, except as
provided in the next sentence, the terms and conditions of this
Agreement and Release shall be kept in confidence. Unless and
until you first obtain written permission from Marc Panoff, in
his capacity as the Company’s Chief Financial Officer, and
only to the extent you obtain such permission, you will not
knowingly disclose this information to anyone, except:
(i) as reasonably necessary to enforce this Agreement and
Release; (ii) to your attorneys or bona fide tax advisors;
(iii) to your spouse; (iv) to governmental taxing
authorities; or, (v) pursuant to compulsory legal process
or a court order.
13. You acknowledge that the
Company has made no promises, commitments or representations to
you other than those contained in this Agreement and Release and
that you have not relied upon any statement or representation
made by the Company with respect to the basis or effect of this
Agreement and Release or otherwise.
4
14. a. You acknowledge that you
have been represented by independent legal counsel of your own
choice (Craig J. Mordock, Esq., Butler Mordock, 8220 Maple
Street, New Orleans, LA 70118 (your “Attorney”))
throughout all of the negotiations preceding the execution of
this Agreement and Release and that you have executed this
Agreement and Release after consultation with your Attorney. You
further acknowledge that you have read this Agreement and
Release in its entirety, that you have had all of its terms and
provisions explained to you by your Attorney, who has answered
any and all questions you have asked with regard to the meaning
of any of the terms and provisions of this Agreement and
Release, and that you fully understand the terms, provisions and
legal effect of this Agreement and Release.
b. You acknowledge that, before
signing this Agreement and Release, you were given a period of
21 days in which to review and consider it; you have, in
fact, carefully reviewed this Agreement and Release; and that
you are entering into it voluntarily and of your own free will.
Further, you acknowledge that the Company encouraged you in
writing to show and discuss this Agreement and Release with your
Attorney before signing it and that, to the extent you wished to
do so, you have done so. If you executed this Agreement and
Release before the end of the
21-day
period, such early execution was completely voluntary, and you
had reasonable and ample time in which to review this Agreement
and Release.
c. You acknowledge that, for a
period of seven days after you sign this Agreement and Release,
you have the right to revoke it by providing notice in writing
to: Marc Panoff, Chief Financial Officer, Neurologix, Inc., One
Bridge Plaza, Suite 605, Fort Lee, NJ 07024, by hand
delivery, or via certified mail or overnight courier. This
Agreement and Release will not become effective and enforceable
until the day after the
seven-day
revocation period (such day after the
seven-day
revocation period is hereafter referred to as the
“Separation Date”).
d. You understand that your
acceptance of the Separation Benefits at any time more than
seven days after you sign this Agreement and Release confirms
that you did not revoke your assent to this Agreement and
Release and, therefore, that it is effective and enforceable.
15. If, at any time after the
Agreement Date, any provision of this Agreement and Release
shall be held by any court of competent jurisdiction to be
illegal, void or unenforceable, such provision shall be of no
force and effect. However, the illegality or unenforceability of
such provision shall have no effect upon, and shall not impair
the enforceability of, any other provision of this Agreement and
Release; provided, however, that if paragraph 7 is held to
be illegal, void or unenforceable, you agree to promptly execute
a valid general release and waiver in favor of the Releasees.
16. This Agreement and Release
contains the entire understanding of the parties with respect to
the subject matter hereof, and supersedes all prior agreements
and understandings, both written and oral, between the parties
with respect to the subject matter hereof, including without
limitation, the Employment Agreement; provided, however, that
Section 5.1 of the Employment Agreement (Non-Competition
and Non-Solicitation), Section 6.1 of the Employment
Agreement (Indemnification), and all provisions of the
Confidentiality Agreement shall remain in full force and effect.
This Agreement and Release may not be changed orally, and no
modification, amendment or waiver of any of the provisions
contained in this Agreement and Release, nor any future
representation, promise or condition in connection with the
subject matter hereof, shall be binding upon any party unless
made in writing and signed by such party.
17. You may not assign any of your
rights or obligations under this Agreement and Release. This
Agreement and Release shall be binding upon and inure to the
benefit of the Company’s successors and assigns. Without
limiting the foregoing, the Company may assign its rights and
delegate its duties hereunder in whole or in part to any
affiliate of the Company or to
5
any transferee of all or a portion of the assets or business to
which this Agreement and Release relates.
18. This Agreement and Release is
governed by the laws of the State of New Jersey, without regard
to its conflict of laws provisions.
19. The Company agrees that should
any action be taken by you to enforce any of the terms and
conditions of this Agreement and Release, you shall, if you are
the prevailing party, be entitled to reimbursement for
reasonable attorney’s fees and costs in connection
therewith.
20. This Agreement and Release may
be executed in one or more counterparts, each of which will be
deemed to be an original but all of which together will
constitute one and the same instrument. This Agreement and
Release may be executed by the delivery of facsimile copies of
the signatures of the parties hereto.
Very truly yours,
Marc Panoff
Chief Financial Officer
6
READ THIS
AGREEMENT AND RELEASE AND CAREFULLY CONSIDER ALL OF ITS
PROVISIONS BEFORE SIGNING IT; IT HAS IMPORTANT LEGAL
CONSEQUENCES AND INCLUDES A RELEASE AND WAIVER OF KNOWN AND
UNKNOWN CLAIMS. CONSULT YOUR ATTORNEY BEFORE SIGNING
IT.
I acknowledge that I have read this Agreement and Release and
that I understand and voluntarily accept its terms.
THIS IS A LEGALLY ENFORCEABLE DOCUMENT.
| |
|
|
|
Accepted and Agreed to:
|
|
|
|
Print Name: John Mordock
|
|
|
|
Signature: /s/ John Mordock
|
|
March 2, 2010_____
|
|
|
|
Date
|
| |
|
|
STATE OF PENNSYLVANIA
COUNTY OF BUCKS
|
|
)
) ss.:***-**-****
)
|
On this 2nd day of March, 2010, before me
personally
came
to me known and known to me to be the person described herein
and who executed the foregoing agreement and general release,
and (s)he duly acknowledged to me that (s)he executed the same.
/s/ Michael
K. McCorriston
Notary Public
7